NVAX - NovavaxAbout Us
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
|
|
|
| Previous Close | $93.59 | Open | $92.84 |
| Volume | 3.11M | Market Cap | 5.735B |
| Yield | Last Dividend |
| Novavax (NASDAQ:NVAX) Cut to Hold at Bid... | 5:58 AM |
| BidaskClub lowered shares of Novavax (NASDAQ:NVAX) from a buy rating to a hold rating in a research report sent to investors on Wednesday, BidAskClub ... | |
| Novavax, Inc. to Post FY2021 Earnings of... | 12:13 AM |
| Novavax, Inc. (NASDAQ:NVAX) ??? Research analysts at B.Riley Securit reduced their FY2021 earnings per share estimates for Novavax in a report issued ... | |
| Novavax (NASDAQ:NVAX) Price Target Cut t... | 10/23/20 |
| Novavax (NASDAQ:NVAX) had its target price decreased by stock analysts at B. Riley from $223.00 to $257.00 in a note issued to investors on Thursday, ... | |
| Novavax (NVAX) Stock Sinks As Market Gai... | 10/23/20 |
| Novavax (NVAX) closed at $93.13 in the latest trading session, marking a -0.49% move from the prior day. | |
| Can Novavax Stock Overcome Growing Vacci... | 10/23/20 |
| NVAX stock may be riding high on AstraZeneca's clinical trial blunder, but the path forward is not smooth for Novavax. Here's why. | |
| Novavax (NASDAQ:NVAX) Shares Down 7.3% | 10/23/20 |
| Shares of Novavax, Inc. (NASDAQ:NVAX) dropped 7.3% on Wednesday . The company traded as low as $90.00 and last traded at $91.16. Approximately 3,386,0... | |
| Coronavirus Hype Is Pushing Novavax to U... | 10/22/20 |
| NVAX stock has to produce the goods before the markets reward it again, as brownie points for gathering funds will only take them so far. | |
| Is It Too Late for Novavax to Profit Fro... | 10/22/20 |
| NVAX stock may actually rise meaningfully above its current levels, as its coronavirus vaccine could still be very profitable. | |
| Novavax (NASDAQ:NVAX) Stock Price Down 7... | 10/21/20 |
| Shares of Novavax, Inc. (NASDAQ:NVAX) fell 7.3% on Wednesday . The stock traded as low as $90.00 and last traded at $91.16. 3,386,098 shares changed h... | |
| Analysts Set Novavax, Inc. (NASDAQ:NVAX)... | 10/21/20 |
| Novavax, Inc. (NASDAQ:NVAX) has received a consensus recommendation of ???Buy??? from the nine brokerages that are currently covering the company, Mar... | |
| Novavax (NASDAQ:NVAX) Stock Rating Lower... | 10/20/20 |
| Novavax (NASDAQ:NVAX) was downgraded by equities research analysts at BidaskClub from a ???buy??? rating to a ???hold??? rating in a research report i... | |
| Novavax Stock Looks Volatile As Vaccine ... | 10/16/20 |
| Catalysts remain in motion for NVAX stock, but high uncertainty makes this an 'all bets are off' situation. | |
| NVAX Stock Has the Perfect Prescription ... | 10/16/20 |
| The possibility of a combined vaccine for influenza and the coronavirus makes NVAX stock a very appealing growth opportunity. | |
| Get Ready To Bull Trade Novavax Stock Fo... | 10/16/20 |
| A promising vaccine combination and longer-term price chart are just what the doctor ordered to turn around downtrodden NVAX stock. | |
| Ukraine under COVAX may receive AstraZen... | 10/16/20 |
| Ukraine, within the framework of the COVAX initiative, may receive vaccines from manufacturers AstraZeneca and Novavax, Deputy Minister of Health, Chi... | |
| New Research Study on Sulfanilamide Mark... | 10/15/20 |
| The Sulfanilamide market 2020 report analyses global acceptance of trends, future growth potential, key drivers, limitations, opportunities, and best ... | |
| Novavax To Evaluate Flu-COVID-19 Vaccine... | 10/13/20 |
| Novavax, Inc. (NASDAQ: NVAX ) shares were advancing strongly Tuesday after the coronavirus vaccine developer announced updates on its influenza and co... | |
| Should you invest in Tandem Diabetes Car... | 10/13/20 |
| NEW YORK, Oct. 13, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for TNDM, APPN, NVAX, RCL, and BA. Click a link below then... | |
| Vaccine Adjuvants Market Size 2020 Indus... | 10/13/20 |
| The Vaccine Adjuvants Market business report provides market shares at global level mainly for Europe, North America, Asia Pacific and South America. ... | |
| MORGAN STANLEY: Buy these 44 cheap stock... | 10/13/20 |
| Summary List Placement Seven months into the coronavirus pandemic, questions still remain around whether the economy is still headed for a V-shaped re... | |
| Novavax Stock Is Incredibly Risky but Wo... | 10/12/20 |
| There's a lot riding on Novavax's novel coronavirus vaccine candidate, making NVAX stock a biotech lottery ticket for bold traders. | |
| Novavax: In The COVID-19 Vaccination Fas... | 10/09/20 |
| Novavax has turned into a credible COVID-19 vaccine play, to my great surprise. The company's over $2 billion of non-dilutive financing has turbo-char... | |
| If You???re Placing Bets on Vaccine Winn... | 10/07/20 |
| Novavax got a manufacturing partner in mid-September to make 2 billion doses. Despite NVAX stock going sideways since then, it remains a buy. | |
| COVID-19 Vaccine Developer Novavax In Sp... | 10/06/20 |
| Novavax, Inc. (NASDAQ: NVAX ) shares, which peaked at $189.40 in early August, gave back some of their gains through August and early September. The s... | |
| Why Is Everyone Talking About Novavax St... | 10/06/20 |
| The vaccine specialist is squarely in the COVID-19 discussion. | |
| Exeter's Nightingale Hospital used for C... | 10/05/20 |
| "This is only the second phase three vaccine study to be initiated in the UK, and the first phase three study with the Novavax vaccine anywhere in the... | |
| Drug cos back appeal for TRIPS waiver fo... | 10/04/20 |
| MUMBAI: A lobby group of large Indian drug companies has endorsed the Indian government???s appeal to the World Trade Organization to waive certain pr... | |
| This group will compare every coronaviru... | 10/02/20 |
| Coronavirus vaccines have been a sensitive topic in recent months. The highly politicized discussions around vaccines in the US have eroded the public... | |
| Buy rating | 08/06/20 |
| HC Wainwright & Co. maintains Buy rating and raises Price Target from $132.00 to $290.00 | |
| Strong Buy rating | 08/05/20 |
| JP Morgan upgrades from Neutral to Overweight rating and raises Price Target from $105.00 to $275.00 | |
| Sell rating | 08/05/20 |
| Ladenburg Thalmann downgrades from Neutral to Sell rating and announces Price Target of $105.00 | |
| Buy rating | 08/05/20 |
| B. Riley FBR maintains Buy rating and raises Price Target from $184.00 to $257.00 | |
| Date | 2020-08-10 (AMC) | Est. (EPS/Rev.) | ($0.42)/ 39.58M |
| Actual (EPS/Rev.) | $-0.30/ $35.54 M | EPS (TTM) | 0 |
| Total Revenue | $1.3B | Total Liabilities | $2.1B |
| Cost of Revenue | $2.5B | Total cash flow | $3.2 |
| Total Assets | $29.98B |
| % Insider | 12.52% | % Institutional | 76.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Vanguard | 12.52% (+6.4%) | Bank of America | 10.43% |
| Service Name | Trader | % Success | |
|---|---|---|---|
| Pennies | Mmkt0652 | 87.00 % | Subscribe |
| Trading Systems | Trading Systems | 83.00 % | Subscribe |
| Tech Trades | Tech Trades | 82.00 % | Follow |
| Big Data Zhou | Zhou Academy | 82.00 % | Subscribe |
| Option Superstars | James Catzen | 75.00 % | Subscribe |
Get winning Stock, Option and Cryptocurrency trade ideas from pro-traders. Follow their strategies, see how they perform.
We are not a registered investment advisor. All investments involve risk, individual's trading does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. References to specific securities should not be construed as a recommendation to buy or sell that security only mentioned for informational purposes.
